Prognostic Factors of Ado-Trastuzumab Emtansine Treatment in Patients With Metastatic HER-2 Positive Breast Cancer
2020
BackgroundAdo-trastuzumab emtansine is an antibody-drug conjugate that combines the cytotoxic activity of emtansine with human epidermal growth factor receptor 2-targeted antitumor features of tras...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
1
Citations
NaN
KQI